ResMed News

Aktie

WKN: 895878 ISIN: US7611521078 US-Symbol: RMD

195,50 €

+1,20 €

+0,62%

07.06.24 15:39:24

Handeln Depot/Watchlist

Aktienanzahl *

146,07 Mio.

Marktkapitalisierung *

28,52 Mrd. €

Streubesitz

Index-Zugehörigkeit

S&P 500

IR-Website

zur Website

*Stand: 31.07.2023

Weiter aufwärts? Long handeln - Jetzt mit Hebel 8,33: HS3NZY

Unternehmensmeldungen

15.03.24 - GlobeNewswire

ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis

36,000 people across 17 markets responded to the company’s fourth annual survey. 40% of respondents get no more than three nights of good sleep per week. More than one-third ...

09.11.23 - GlobeNewswire

ResMed Adopts New Operating Model to Accelerate Long-term Growth

Justin Leong appointed Chief Product Officer, effective immediately. Katrin Pucknat appointed Chief Marketing Officer, effective immediately. Mike Fliss appointed Chief Revenue ...

05.07.23 - GlobeNewswire

ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software

Expands ResMed’s sleep management software solution, will help sleep labs and physicians more efficiently guide patients into and through diagnosis to long-term treatment ...

08.06.23 - GlobeNewswire

PAP Adherence Lowers ER Visits 24-36% in 1 Year for People with Sleep Apnea and Heart Failure: ResMed Studies Presented at SLEEP

The studies also showed 18-40% lower costs incurred from ER visits and hospitalizations after 1 year for PAP-adherent OSA patients with diastolic and systolic heart failure, ...

25.05.23 - GlobeNewswire

3 World-Renowned Sleep Apnea Experts Present New Benefits of PAP Therapies at ATS 2023

France’s Jean-Louis Pépin and Germany’s Holger Woehrle presented studies in which treating OSA with CPAP lowered all-cause mortality for PAP vs. non-PAP users with OSA ...

02.05.23 - GlobeNewswire

ResMed Appoints Michael Rider its Next Global General Counsel, Dawn Haake its First Chief Quality Officer

Rider and Haake, both internal promotions, joined ResMed’s executive team on May 1 Rider, currently Senior Vice President, Deputy Global General Counsel will succeed retiring ...

30.03.23 - GlobeNewswire

ResMed Chief Administrative Officer and Global General Counsel to Retire

ResMed to conduct an internal search for a successor general counsel Amy Wakeham appointed Chief Communications and Investor Relations Officer, will join ResMed’s executive ...

13.03.23 - GlobeNewswire

ResMed’s Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of Sleep

81% of respondents experience one or more symptoms indicating poor sleep quality, despite 64% saying they’re satisfied with the quantity of their sleep Women and older ...

26.01.23 - GlobeNewswire

ResMed Appoints Michael Farrell as Chair of its Board of Directors Peter Farrell to Become Chair Emeritus

SAN DIEGO, Jan. 26, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced ResMed’s board of directors has appointed chief executive officer Michael ...

22.11.22 - GlobeNewswire

ResMed Completes Acquisition of MEDIFOX DAN, a German Leader in Out-of-Hospital Care Management Software Solutions

- Acquisition expands ResMed’s SaaS business to Germany, first non-U.S. market

04.09.22 - GlobeNewswire

Over 480 Million People Estimated to Have COPD, World’s Third Deadliest Disease, ResMed Study Reports

New prevalence figure 22–126% higher than previous estimates Prevalence expected to reach 592 million by 2050 Researchers urge global action on smoking cessation and air ...

28.06.22 - GlobeNewswire

ResMed Promotes Lucile Blaise to President, Sleep & Respiratory Care

Blaise is a medtech industry thought leader with over 25 years’ experience A board member of MedTech Europe since 2020; President of the Snitem, France’s premier medtech ...

14.06.22 - GlobeNewswire

ResMed to Acquire MEDIFOX DAN, a German Leader in Out-of-Hospital Software Solutions

Acquisition creates a global leader in out-of-hospital software solutions Accelerates ResMed’s SaaS strategy by extending ResMed’s position as a leading U.S. provider of SaaS ...

25.05.22 - GlobeNewswire

ResMed Announces Participation in the 38th Annual Bernstein Strategic Decisions Conference

SAN DIEGO, May 25, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a fireside chat at the ...

18.05.22 - GlobeNewswire

Even 2 Hours of PAP Therapy per Night Benefits Sleep Apnea Sufferers: ResMed Study

2–3 hours of nightly PAP use shows health benefits at 3 months, 1 year, and 2 years Health benefits significantly increase by use hour/night, up to 7 hours SAN FRANCISCO, May 18, ...

05.05.22 - GlobeNewswire

ResMed Announces Leadership Change

SAN DIEGO, May 05, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced that Jim Hollingshead, President, Sleep and Respiratory Care, has informed ...

28.04.22 - GlobeNewswire

ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2022

Year-over-year revenue grows 12%, operating profit up 5%, non-GAAP operating profit up 5% Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at ...

27.04.22 - GlobeNewswire

ResMed Announces Participation in the 24th Annual Macquarie Australia Conference

SAN DIEGO, April 27, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Brett Sandercock, chief financial officer, will present virtually at the Macquarie ...

07.04.22 - GlobeNewswire

ResMed to Report Third Quarter Fiscal 2022 Earnings on April 28, 2022

SAN DIEGO, April 07, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of ...

17.03.22 - GlobeNewswire

ResMed Announces Participation in the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum

SAN DIEGO, March 17, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at ...

Newssuche

Videos

06.06.24 +3,57%

Technical Trading: Erdgas nach Rücksetzer Long

Erdgas Long Typ: Turbo Open End WKN: VM6KAH Hebel: 2,11 Laufzeit: OpenEnd Einstieg: Market ... Mehr »

Weitere Videos